Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Morens

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Npj Viruses|April 28, 2025
Yellow Jack: a modern threat to Asia-Pacific countries?Duane J Gubler, Kathryn A Hanley, Thomas P Monath, et al.
The Journal of Infectious Diseases|August 10, 2005
A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusceptionAlbert Z Kapikian, Lone Simonsen, Timo Vesikari, et al.
Influenza and Other Respiratory Viruses|April 23, 2010
Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virusJohn C Kash, Li Qi, Vivien G Dugan, et al.
The Journal of Infectious Diseases|July 12, 2012
Dengue research opportunities in the AmericasCatherine A Laughlin, David M Morens, M Cristina Cassetti, et al.
The American Journal of Tropical Medicine and Hygiene|May 10, 2021
Seasonal Influenza Prevention and Control Progress in Latin America and the Caribbean in the Context of the Global Influenza Strategy and the COVID-19 PandemicAndrea S Vicari, Daniel Olson, Alba Vilajeliu, et al.
Virology|June 26, 2012
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in miceJudith D Easterbrook, Louis M Schwartzman, Jin Gao, et al.
Microbiology and Molecular Biology Reviews : MMBR|September 6, 2008
Cross-species virus transmission and the emergence of new epidemic diseasesColin R Parrish, Edward C Holmes, David M Morens, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peakZong-Mei Sheng, Daniel S Chertow, Xavier Ambroggio, et al.
The American Journal of Tropical Medicine and Hygiene|July 24, 2020
The Origin of COVID-19 and Why It MattersDavid M Morens, Joel G Breman, Charles H Calisher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2019
Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine DevelopmentMatthew J Memoli, Alison Han, Kathie-Anne Walters, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Npj Viruses|April 28, 2025
Yellow Jack: a modern threat to Asia-Pacific countries?Duane J Gubler, Kathryn A Hanley, Thomas P Monath, et al.
The Journal of Infectious Diseases|August 10, 2005
A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusceptionAlbert Z Kapikian, Lone Simonsen, Timo Vesikari, et al.
Influenza and Other Respiratory Viruses|April 23, 2010
Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virusJohn C Kash, Li Qi, Vivien G Dugan, et al.
The Journal of Infectious Diseases|July 12, 2012
Dengue research opportunities in the AmericasCatherine A Laughlin, David M Morens, M Cristina Cassetti, et al.
The American Journal of Tropical Medicine and Hygiene|May 10, 2021
Seasonal Influenza Prevention and Control Progress in Latin America and the Caribbean in the Context of the Global Influenza Strategy and the COVID-19 PandemicAndrea S Vicari, Daniel Olson, Alba Vilajeliu, et al.
Virology|June 26, 2012
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in miceJudith D Easterbrook, Louis M Schwartzman, Jin Gao, et al.
Microbiology and Molecular Biology Reviews : MMBR|September 6, 2008
Cross-species virus transmission and the emergence of new epidemic diseasesColin R Parrish, Edward C Holmes, David M Morens, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peakZong-Mei Sheng, Daniel S Chertow, Xavier Ambroggio, et al.
The American Journal of Tropical Medicine and Hygiene|July 24, 2020
The Origin of COVID-19 and Why It MattersDavid M Morens, Joel G Breman, Charles H Calisher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2019
Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine DevelopmentMatthew J Memoli, Alison Han, Kathie-Anne Walters, et al.
Pageof 12